Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for relieving mycteroxerosis as well as preparation method and use method of composition

A technology of nasal cavity dryness and composition, applied in the medical field, can solve the problems of aggravating nasal cavity dryness, lack of dry rhinitis material components, inability to achieve, etc., and achieves the effects of preventing excessive edema, scientific prescription ratio and high practicability

Active Publication Date: 2019-09-27
WENZHOU MEDICAL UNIV
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The method of removing external causes is the most reliable, but it is often impossible to achieve it in real life without contacting external stimuli
At present, most of the nasal cavity care products on the market have the functions of inhibiting the growth of nasal bacteria, inhibiting the secretion of inflammatory factors, shrinking mucosal blood vessels, and anti-allergic effects. Nasal drops can even worsen symptoms of nasal dryness

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0034] The present invention also provides a preparation method of the composition for relieving dryness of the nasal cavity, which comprises the following steps:

[0035] A. Mix lubricant, moisturizer, microcirculation improver and skin repairing agent, add about 50 parts by weight of distilled water at room temperature and pressure, and stir evenly;

[0036] B. Add an osmotic regulator to the mixture in step A, then add distilled water to 100 parts by weight, and stir and dissolve at room temperature and pressure.

[0037] The composition of the present invention is different from the common nasal drops in the prior art, which are usually developed to remove the cause of the disease, or common care products to inhibit the growth of nasal bacteria, inhibit the secretion of inflammatory factors, contract mucosal blood vessels, anti-allergic, etc. In order to improve the nasal environment, lubricants (glycerol, butanediol, medical-grade white oil) and moisturizers (hyaluronic acid, ...

Embodiment 1

[0040] A composition for relieving nasal dryness, including glycerol, hyaluronic acid, sodium chloride, dextran 40, dipotassium glycyrrhizinate and allantoin.

[0041] To prepare 100 g of the composition, weigh the components as follows:

[0042] Glycerol: 10g;

[0043] Hyaluronic acid: 0.25g;

[0044] Sodium chloride: 12g;

[0045] Dextran 40: 0.1g;

[0046] Allantoin: 0.2g;

[0047] Dipotassium Glycyrrhizinate: 0.2g;

[0048] Add distilled water to 100g.

[0049] The preparation process of the composition is:

[0050] First add about 50g of distilled water to the above weight of glycerol, hyaluronic acid, dextran 40, allantoin, and dipotassium glycyrrhizinate, and stir evenly at room temperature and pressure, then add sodium chloride, add to 100g with distilled water, and stir. After 10 minutes, it is the original solution after standing, and it is the finished product when it is diluted 100 times with normal saline or mineral water during use.

Embodiment 2

[0052] A composition for relieving dryness of the nasal cavity, including butylene glycol, aloe extract, sodium chloride, dextran 40, and allantoin.

[0053] To prepare 100 g of the composition, weigh the components as follows:

[0054] Butylene glycol: 5g;

[0055] Aloe extract: 0.15g;

[0056] Sodium chloride: 15g;

[0057] Dextran 40: 0.1g;

[0058] Allantoin: 0.1g;

[0059] Add distilled water to 100g.

[0060] The preparation process of the composition for relieving dryness of the nasal cavity is:

[0061] First add about 50g of distilled water to the above weight of butylene glycol, aloe extract, sodium chloride, dextran 40, and allantoin, and stir evenly at room temperature and pressure, then add sodium chloride, add 100g with distilled water, and stir for 10 Minutes, after standing still, it becomes the original solution, diluted 100 times with normal saline or mineral water to spray or drip the finished product into the nasal cavity.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition for relieving mycteroxerosis. The composition is prepared from a lubricant, a humectant, an osmotic regulating agent, a microcirculation improver and a skin restoration agent; the composition is specifically prepared from the following components in parts by weight in every 100 parts: 5 to 20 parts of a lubricant, 0.1 to 0.25 part of a humectant, 10 to 15 parts of an osmotic regulating agent, 0.1 part of a microcirculation improver, 0.1 to 0.5 part of a skin restoration agent and the balance of distilled water. The composition disclosed by the invention can fully exert the excellent lubricating and moisturizing functions, and benefit the nasal ventilation while maintaining appropriate humidity of a nasal environment; meanwhile, the microcirculation improver and the skin restoration agent can improve minor wound caused by dryness, keep nasal mucosa complete and healthy and improve various nasal problems. The composition disclosed by the invention has the advantages of safe components, high practicality, scientific prescription ratio and easiness in popularization.

Description

Technical field [0001] The present invention relates to the field of medical technology, in particular to a composition for relieving dryness of the nasal cavity, and a preparation method and use method thereof. Background technique [0002] Dry rhinitis is generally considered to be caused by long-term external physical or chemical stimulation, such as long-term mechanical irritation from dust, and the effects of excessive heat and dry air. This disease is a common occupational chronic rhinitis. When sicca rhinitis is not treated in time and affects the olfactory mucosa, olfactory disorders will occur, which will affect mental and physical development. Respiratory obstruction will cause hypoxia in the brain and cause dizziness and drowsiness. In addition, due to poor exhalation and mouth breathing, it will directly stimulate the pharyngeal cavity and cause pharyngitis. If this happens, the lips will become thicker and the teeth will develop outward, leading to facial deformitie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K47/10A61K47/22A61K47/26A61K47/28A61K47/36A61K47/46A61P11/02
CPCA61K9/0043A61K9/08A61K47/10A61K47/22A61K47/26A61K47/28A61K47/36A61K47/46A61P11/02
Inventor 周铁丽陈涛曹建明方人驰喻凯航
Owner WENZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com